|
Volumn 36, Issue 7, 2004, Pages 2172-2174
|
Impact of HLA-identity on results of ABO-incompatible living kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
BLOOD GROUP ABO INCOMPATIBILITY;
CHRONIC GRAFT REJECTION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG UTILIZATION;
FEMALE;
GRAFT REJECTION;
HLA MATCHING;
HLA SYSTEM;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
ISCHEMIA;
KIDNEY DONOR;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MAJOR CLINICAL STUDY;
MALE;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RECIPIENT;
SIBLING;
SPLENECTOMY;
SURGICAL PATIENT;
SURVIVAL RATE;
SURVIVAL TIME;
TIME;
ABO BLOOD-GROUP SYSTEM;
ADULT;
BLOOD GROUP INCOMPATIBILITY;
FEMALE;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY TESTING;
HUMANS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SIBLINGS;
SURVIVAL ANALYSIS;
|
EID: 7044240851
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.093 Document Type: Conference Paper |
Times cited : (6)
|
References (2)
|